A detailed history of Prosight Management, LP transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 5,678,726 shares of STTK stock, worth $6.19 Million. This represents 5.32% of its overall portfolio holdings.

Number of Shares
5,678,726
Previous 4,670,000 21.6%
Holding current value
$6.19 Million
Previous $18 Million 9.94%
% of portfolio
5.32%
Previous 5.63%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.0 - $4.85 $3.03 Million - $4.89 Million
1,008,726 Added 21.6%
5,678,726 $19.8 Million
Q2 2024

Aug 14, 2024

BUY
$3.56 - $11.18 $3.36 Million - $10.6 Million
945,000 Added 25.37%
4,670,000 $18 Million
Q1 2024

May 15, 2024

BUY
$7.37 - $10.09 $6.94 Million - $9.51 Million
942,203 Added 33.86%
3,725,000 $33.3 Million
Q4 2023

Feb 14, 2024

BUY
$1.37 - $7.24 $903,921 - $4.78 Million
659,797 Added 31.08%
2,782,797 $19.8 Million
Q3 2023

Nov 14, 2023

BUY
$1.42 - $3.16 $18,999 - $42,280
13,380 Added 0.63%
2,123,000 $3.23 Million
Q2 2023

Aug 14, 2023

BUY
$2.52 - $3.66 $221,639 - $321,904
87,952 Added 4.35%
2,109,620 $6.58 Million
Q1 2023

May 12, 2023

SELL
$2.5 - $4.72 $229,562 - $433,414
-91,825 Reduced 4.34%
2,021,668 $5.94 Million
Q4 2022

Feb 14, 2023

BUY
$1.96 - $3.26 $1.95 Million - $3.24 Million
992,717 Added 88.57%
2,113,493 $4.86 Million
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.52 $262,017 - $556,283
100,776 Added 9.88%
1,120,776 $3.03 Million
Q2 2022

Aug 12, 2022

BUY
$2.7 - $4.59 $597,461 - $1.02 Million
221,282 Added 27.7%
1,020,000 $4.14 Million
Q1 2022

May 16, 2022

BUY
$4.22 - $8.89 $2.27 Million - $4.79 Million
538,475 Added 206.91%
798,718 $3.4 Million
Q4 2021

Feb 14, 2022

BUY
$8.36 - $21.08 $760,776 - $1.92 Million
91,002 Added 53.77%
260,243 $2.22 Million
Q3 2021

Nov 12, 2021

BUY
$17.57 - $28.95 $2.97 Million - $4.9 Million
169,241 New
169,241 $3.45 Million

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $46.2M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.